Paradigm Clinical Research’s Post

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center presents an invaluable tool: the Clinical Research Glossary, with over 165 terms explained in plain language. It's designed to clarify complex concepts for patients and participants, enhancing understanding and engagement in clinical trials. Access this comprehensive resource for your communication needs. https://bit.ly/3UkwmYy

Our latest Perceptions and Insights Study revealed diversity gaps in clinical research. Read our article to learn what opportunities can improve clinical trial recruitment and participation, particularly among underrepresented populations. Read here: https://lnkd.in/dkH7RxXQ

A Cross-Sectional Study of Patient Perspectives on Clinical Trial Participation in a Large Community-Based Research Facility https://buff.ly/48mtPBb #clinicaltrials #clinicalstudy #clinicalresearch

Participating voluntarily in a clinical trial is a commendable decision, but it's essential to approach it with caution and understanding. Here's a general guide on how to participate Croissance Clinical Research #patient #clinicaltrail Satish Marukurthi

To help patients and families make informed decisions about participating in clinical research, the MRCT Center of Brigham and Women's Hospital and Harvard University, along with patient advocates and research professionals, has created a plain-language Clinical Research Glossary. This resource, available for free download, features 167 definitions complete with images and related resources, all rigorously reviewed by the public to set a global standard. You can find many terms implemented in Cure Mito glossary: https://lnkd.in/evRe3Mu9 Learn more about the glossary here: https://lnkd.in/ezmvngCp #leighsyndrome #mitochondrialdisease

Building trust in communities that have been historically underrepresented in clinical studies is an important step to expanding diversity in clinical trials. Andrew Trister, MD PhD, our Chief Medical and Science Officer discussed strategies to make progress while at the recent Milken Institute Global Conference: “Clinical trials are more successful when participants feel like they’re centered in the process. One way to reflect this is in the language associated with clinical trial participation.” “Even the language that we use when we talk about clinical studies represents a change in the hierarchy and shifts how the trust relationship works — a person becomes a subject in a study as opposed to being a patient.” Read more in STAT: https://bit.ly/3ypaLWu #MIGlobal #ClinicalTrials #HealthEquity #PrecisionHealth

Embracing #Diversity in Clinical Trials   Clinical trials are the cornerstone of medical advancement, paving the way for groundbreaking treatments and therapies. Yet, to truly unlock the potential of these innovations, we must recognize and address a critical gap: the lack of diversity in participant representation.   Diverse populations bring unique perspectives and genetic variability, enriching the data and ensuring that medical breakthroughs are universally applicable. Sadly, underrepresentation in clinical trials perpetuates health disparities, hindering our ability to understand the full spectrum of responses to treatments.   It's time to bridge the gap and champion inclusivity in clinical research. By embracing diversity, we empower research outcomes that resonate across communities. ODC is committed to enhancing diversity in clinical trials by operating in #LatinAmerica. For more information and to discuss potential collaborations, schedule a call with us by emailing [email protected]. Join us in this vital effort for science and health!   #ClinicalTrials #DiversityInResearch #LATAMHealthcare #PatientDiversity #PatientRecruitment #ClinicalDevelopment

Check this great reference for clinical research professionals that can help us to discuss clinical trials concepts to patients in a way that can be understood by all.

To effectively increase the conduct of clinical trials in Brazil, it's crucial to ensure expedited recruitment processes and to guarantee representative diversity among participants. This approach stands out as an excellent positive aspect for Latin America in the global context of clinical research.

Diversifying #ClinicalTrials research is a high priority in our strategic framework. 💡 The fourth pillar of our strategic framework states that "NMF will provide an onramp for physicians and students underrepresented in medicine to become clinical investigators and lead community-oriented research. Through innovative programs that offer clinical research career pathways, professional development, and mentoring, NMF will diversify the investigators and participants in clinical research. Such change will ensure resulting therapeutics and disease prevention efforts have greater efficacy across all populations." Find out more about how you can work towards diversifying clinical trails research too: https://bit.ly/3nTtIvG Apply by Friday, May 17 at 11:59 p.m. ET to join the June cohort. #DiversityInMedicine #HealthCare